Aimmune Therapeutics (AIMT) closed at $29.17 in the latest trading session, marking a -1.12% move from the prior day. This change lagged the S&P 500's daily gain of 0.65%. At the same time, the Dow ...

Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us ...

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks ...

As of late, it has definitely been a great time to be an investor in Aimmune Therapeutics Inc AIMT. The stock has moved higher by 27.1% in the past month, while it is also above its 20 Day SMA too.

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...

Investors certainly have to be happy with Aimmune Therapeutics, Inc.AIMT and its short term performance. After all, the stock has jumped by 9.5% in the past 4 weeks, and it is also above its 20 Day ...

It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing ...

Aimmune Therapeutics (AIMT) closed at $29.17 in the latest trading session, marking a -1.12% move from the prior day. This change lagged the S&P 500's daily gain of 0.65%. At the same time, the Dow ...